Search research articles
Contact Us
Filters
Showing results (441-450 of 461) with videos related to
Page
of 47
Sort By:
The International Journal of Biological Markers
|
February 15, 2014
Significance of platelet and AFP levels and liver function parameters for HCC size and survival
Brian I Carr, Vito Guerra, Edoardo G Giannini, et al.
The International Journal of Biological Markers
|
June 8, 2018
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients
Brian I Carr, Gianluigi Giannelli, Vito Guerra, et al.
The International Journal of Biological Markers
|
May 17, 2014
Low alpha-fetoprotein HCC and the role of GGTP
Brian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy
R J Morgan, T Synold, B I Carr, et al.
Transplantation Proceedings
|
June 1, 1997
Quantitative assessment of the development of hepatoma in a buffalo rat model
J R Madariaga, V M Subbotin, S R Lopez, et al.
Molecular Cancer Research : MCR
|
January 4, 2022
DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy
Michael I Carr, Li-Ya Chiu, Yige Guo, et al.
Hepatology (Baltimore, Md.)
|
November 22, 2007
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M Kulik, Brian I Carr, Mary F Mulcahy, et al.
International Journal of Clinical Practice
|
June 26, 2020
Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
Hikmet Akkiz, Brian I Carr, Harika G Bag, et al.
Journal of Translational Science
|
September 20, 2021
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis
B I Carr, H Akkiz, H G Bag, et al.
Cancer
|
July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
Han Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 461) with videos related to
Sort By:
Page
of 47
The International Journal of Biological Markers
|
February 15, 2014
Significance of platelet and AFP levels and liver function parameters for HCC size and survival
Brian I Carr, Vito Guerra, Edoardo G Giannini, et al.
The International Journal of Biological Markers
|
June 8, 2018
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients
Brian I Carr, Gianluigi Giannelli, Vito Guerra, et al.
The International Journal of Biological Markers
|
May 17, 2014
Low alpha-fetoprotein HCC and the role of GGTP
Brian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Cancer Chemotherapy and Pharmacology
|
May 11, 2001
Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy
R J Morgan, T Synold, B I Carr, et al.
Transplantation Proceedings
|
June 1, 1997
Quantitative assessment of the development of hepatoma in a buffalo rat model
J R Madariaga, V M Subbotin, S R Lopez, et al.
Molecular Cancer Research : MCR
|
January 4, 2022
DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy
Michael I Carr, Li-Ya Chiu, Yige Guo, et al.
Hepatology (Baltimore, Md.)
|
November 22, 2007
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M Kulik, Brian I Carr, Mary F Mulcahy, et al.
International Journal of Clinical Practice
|
June 26, 2020
Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
Hikmet Akkiz, Brian I Carr, Harika G Bag, et al.
Journal of Translational Science
|
September 20, 2021
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis
B I Carr, H Akkiz, H G Bag, et al.
Cancer
|
July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
Han Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Page
of 47